Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Wednesday, September 22, 2010

Investorideas.com - Actively Trading Pharma/Biotech Stocks: OTCVolumeleaders.com Reports on OTCBB Market ($2.00-$5.00): (OTCBB: KMKCF), (OTCBB: BOPH), (OTCBB: ACCP), (OTCBB: QPSA)

Investorideas.com - Actively Trading Pharma/Biotech Stocks: OTCVolumeleaders.com Reports on OTCBB Market ($2.00-$5.00): (OTCBB: KMKCF), (OTCBB: BOPH), (OTCBB: ACCP), (OTCBB: QPSA)



Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS
Category: Investment, Financial


Subscribe to Investor Ideas Newswire
Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) September 22, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($2.00-$5.00) include CONTINENTAL MINERALS (OTCBB: KMKCF), Bohai Pharmaceuticals Group, Inc. (OTCBB: BOPH), Access Pharmaceuticals Inc. (OTCBB: ACCP), and Quepasa Corp. (OTCBB: QPSA).




Sign up at OTC Volume leaders and get access to info on hundreds of the most active OTCBB companies by clicking the sign up link belowhttp://bit.ly/otcvolumeleaders
OTC/Market Commentary:
One of the OTCBB volume leader reports; Recent News: "Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc. ("RHEI"), a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories. Coinciding with the signing of the above agreement, Access also approved a sub-license agreement between RHEI Pharmaceuticals and Jian An Pharmaceuticals ("Jian An") Limited in Shenzhen, China in an effort to leverage Jian An's extensive sales, marketing and regulatory infrastructure for the launch of MuGard in China and Taiwan."
Full Article: http://finance.yahoo.com/news/Access-Pharmaceuticals-Inc-prnews-1403730987.html?x=0&.v=1

Market Snapshot: (at time of release)
Dow 10,746.39 -14.64 -0.14%
Nasdaq 2,333.63 -15.72 -0.67%
S&P 500 1,135.01 -4.77 -0.42%
10 Yr Bond(%) 2.5480% -0.4600
Oil 74.69 -0.28 -0.37%
Gold 1,290.00 +17.60 +1.38%


OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/

Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader


* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC

Investors - Get OTC stock quotes from http://www.otcmarkets.com

Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments:

Post a Comment